Acupuncture in patients suffering from allergic asthma: Is it worth additional costs?

Journal of Alternative and Complementary Medicine

Volumn 20, Issue 3, 2014, Pages 169-177

  Reinhold, Thomas ^a   Brinkhaus, Benno ^a   Willich, Stefan N ^a   Witt, Claudia ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUPUNCTURE; ADULT; ALLERGIC ASTHMA; ARTICLE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; FEMALE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL;

ACUPUNCTURE THERAPY; ADULT; ASTHMA; CLUSTER ANALYSIS; COST-BENEFIT ANALYSIS; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 84895725034     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2012.0719     Document Type: Article

References (29)

1. Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: A retrospective cohort study. Respir Res 2005;6:153
2. Peters SP, Ferguson G, Deniz Y, Reisner C. Uncontrolled asthma: A review of the prevalence, disease burden and options for treatment. Respir Med 2006;100:1139-1151
3. Demoly P, Paggiaro P, Plaza V, et al. Prevalence of asthma control among adults in France, Germany, Italy, Spain and the UK. Eur Respir Rev 2009;18:105-112
4. Briggs AH, Bousquet J, Wallace MV, et al. Cost-effectiveness of asthma control: An economic appraisal of the GOAL study. Allergy 2006;61:531-536
5. Corren J. The connection between allergic rhinitis and bronchial asthma. Curr Opin Pulm Med 2007;13:13-18
6. Bahadori K, Doyle-Waters MM, Marra C, et al. Economic burden of asthma: A systematic review. BMC Pulm Med 2009;9:24
7. Schramm B, Ehlken B, Smala A, et al. Cost of illness of atopic asthma and seasonal allergic rhinitis in Germany: 1-yr retrospective study. Eur Respir J 2003;21:116-122
8. The Federal Health Monitoring, Federal Statistical Office Germany (2012) Medical costs in million e for Germany. Online document at: Http://www.gbe-bund. de/Accessed August 22, 2012
9. The Federal Health Monitoring, Federal Statistical Office Germany (2012) Structure of asthma costs in international comparison. Online document at: Http://www.gbe-bund.de/ Accessed August 22, 2012
10. Schafer T, Riehle A, Wichmann HE, Ring J. Alternative medicine in allergies: Prevalence, patterns of use, and costs. Allergy 2002;57:694-700
11. Paterson C, Britten N. Acupuncture as a complex intervention: A holistic model. J Altern Complement Med 2004;10: 791-801
12. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: An extension of the CONSORT statement. BMJ 2008;337:a2390
13. Witt C, Brinkhaus B, Jena S, et al. Effectiveness, safety and efficiency of acupuncture: Demonstration Project acupuncture by the Technicians' Health Insurance Company. Deutsch Ärztebl 2012;103:A187-A195
14. Hanoverian Consensus-Group. German Recommendations for health economic evaluations: Revised version of the Hanover Consensus. Gesundh Ökon Qual Manag 1999;4: A62-A65
15. Bullinger M, Kirchberger I. SF-36 Health Survey, Manual. GÖttingen: Hogrefe, 1998
16. Brazier J, Roberts J, Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ 2002;21:271-292
17. Richardson G, Manca A. Calculation of quality adjusted life years in the published literature: A review of methodology and transparency. Health Econ 2004;13:1203-1210
18. Thompson SG, Barber JA. How should cost data in pragmatic randomised trials be analysed? BMJ 2000;320:1197-1200
19. Greenberg D, Winkelmayer WC, Neumann PJ. Prevailing judgments about society's willingness to pay for QALY or life-year gained. Int J Public Health 2005;2(Suppl 1):301
20. Zethraeus N, JohannessonM, Jonsson B, et al. Advantages of using the net-benefit approach for analysing uncertainty in economic evaluation studies. Pharmacoeconomics 2003;21: 39-48
21. Lothgren M, Zethraeus N. Definition, interpretation and calculation of cost-effectiveness acceptability curves. Health Econ 2000;9:623-630
22. Efron B. Bootstrap methods: Another look at the jackknife. Ann Statist 1979;7:1-26
23. Witt CM, Jena S, Selim D, et al. Pragmatic randomized trial evaluating the clinical and economic effectiveness of acupuncture for chronic low back pain. Am J Epidemiol 2006; 164:487-496
24. Reinhold T, Witt CM, Jena S, et al. Quality of life and costeffectiveness of acupuncture treatment in patients with osteoarthritis pain. Eur J Health Econ 2008;9:209-219
25. Willich SN, Reinhold T, Selim D, et al. Cost-effectiveness of acupuncture treatment in patients with chronic neck pain. Pain 2006;125:107-113
26. Witt CM, Brinkhaus B. Efficacy, effectiveness and cost-effectiveness of acupuncture for allergic rhinitis: An overview about previous and ongoing studies. Auton Neurosci 2010; 157:42-45
27. Witt CM, Reinhold T, Jena S, et al. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: A randomized controlled study in usual care. Am J Epidemiol 2009;169:562-571
28. Polosa R, Al-Delaimy WK, Russo C, et al. Greater risk of incident asthma cases in adults with allergic rhinitis and effect of allergen immunotherapy: A retrospective cohort study. Respir Res 2005;6:153
29. Sazonov V, Ambegaonkar BM, Bolge SC, et al. Frequency of diagnosis and treatment of allergic rhinitis among adults with asthma in Germany, France, and the UK: National Health and Wellness Survey. Curr Med Res Opin 2009;25: 1721-1726